GlassScriptPhysician profile
Kiamesha Jones
NPI 1518733492
$1,359.93
in general payments reported to CMS, 2019-2025
12 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what 87% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $207 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,359.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $224.50 | 2025 | Datroway, Enhertu |
| Astrazeneca Pharmaceuticals LP | $205.05 | 2025 | Datroway |
| Janssen Biotech, INC. | $134.00 | 2025 | Carvykti, Rybrevant |
| Incyte Corporation | $131.80 | 2025 | Jakafi |
| Stemline Therapeutics INC. | $124.97 | 2025 | Orserdu |
| Gilead Sciences, INC. | $121.85 | 2025 | Trodelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $121.82 | 2025 | Alunbrig |
| Servier Pharmaceuticals LLC | $105.25 | 2024 | |
| Merck Sharp & Dohme LLC | $101.41 | 2024 | Keytruda |
| Glaxosmithkline, LLC. | $41.63 | 2025 | Zejula, Jemperli |
| Verastem, INC. | $26.68 | 2025 | Avmapki Fakzynja Co-Pack |
| Genentech USA, INC. | $20.97 | 2025 | Phesgo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kiamesha Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.